Reply to thread

FDA will be reviewing DRP in April of 2021.  Start dates may be pushed to Jan 2021 or later.   Access is going to be a challenge for retail and LTC but you have to overcome it and not wine about it.

How will you address this obstacle to gain access with Covid still running wild in 2021??